Association between EGF +61 G/A and glioma risk in a Chinese population

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Wang, Shujie ^a   Zhao, Yao ^b   Ruan, Zhenchao ^a   Chen, Hongyan ^a   Fan, Weiwei ^a   Chen, Juxiang ^c   Wu, Qihan ^d   Qian, Ji ^a   Zhang, Tianbao ^e   Huang, Yan ^a   Lu, Daru ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d EAST CHINA NORMAL UNIVERSITY   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CANCER RISK; CASE CONTROL STUDY; CHILD; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; BRAIN TUMOR; CHI SQUARE DISTRIBUTION; CHINA; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PHENOTYPE; PRESCHOOL CHILD; RISK; SMOKING; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHINA; EPIDERMAL GROWTH FACTOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 77952454420     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-221     Document Type: Article

References (58)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114(2):97-109. 10.1007/s00401-007-0243-4, 1929165, 17618441.
2. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci 2007, 64(4):458-478. 10.1007/s00018-007-6342-5, 17260089.
3. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998, 88(1):1-10. 10.3171/jns.1998.88.1.0001, 9420066.
4. Mangiola A, Lama G, Giannitelli C, De Bonis P, Anile C, Lauriola L, La Torre G, Sabatino G, Maira G, Jhanwar-Uniyal M, et al. Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res 2007, 13(23):6970-6977. 10.1158/1078-0432.CCR-07-1229, 18056172.
5. Drappatz J, Norden AD, Wen PY. Therapeutic strategies for inhibiting invasion in glioblastoma. Expert Rev Neurother 2009, 9(4):519-534. 10.1586/ern.09.10, 19344303.
6. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002, 4(4):278-299. 10.1215/15228517-4-4-278, 1920665, 12356358.
7. Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K, Lee M, Liu J, Wrensch M. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 2000, 9(8):843-847.
8. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962, 237:1555-1562.
9. Morton CC, Byers MG, Nakai H, Bell GI, Shows TB. Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22----q24.1, 11p15, and 4q25----q27, respectively. Cytogenet Cell Genet 1986, 41(4):245-249. 10.1159/000132237, 3486749.
10. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979, 48:193-216. 10.1146/annurev.bi.48.070179.001205, 382984.
11. Wong RW, Guillaud L. The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev 2004, 15(2-3):147-156. 10.1016/j.cytogfr.2004.01.004, 15110798.
12. Nicholas MK, Lukas RV, Jafri NF, Faoro L, Salgia R. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas. Clinical Cancer Research: An Official Journal Of The American Association For Cancer Research 2006, 12(24):7261-7270.
13. Bello L. Urinary epidermal growth factor (EGF) levels and epidermal growth factor receptor (EGF-R) expression in human cerebral tumors. Clinical considerations. J Neurosurg Sci 1996, 40(3-4):167-182.
14. Shahbazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, Strange RC, Hutchinson PE, Osborne JE, Lear JT, Smith AG, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002, 359(9304):397-401. 10.1016/S0140-6736(02)07600-6, 11844511.
15. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer. Hum Immunol 2008, 69(6):360-367. 10.1016/j.humimm.2008.04.004, 18571008.
16. Watanabe Y, Fukui N, Muratake T, Kaneko N, Someya T. No association of EGF polymorphism with schizophrenia in a Japanese population. Neuroreport 2005, 16(4):403-405. 10.1097/00001756-200503150-00019, 15729146.
17. Lim YJ, Kim JW, Song JY, Hong MS, Jin SY, Yoon SH, Park HJ, Choe BK, Lee JJ, Yim SV, et al. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett 2005, 374(3):157-160. 10.1016/j.neulet.2004.10.055, 15663953.
18. Goto Y, Ando T, Goto H, Hamajima N. No association between EGF gene polymorphism and gastric cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(10):2454-2456. 10.1158/1055-9965.EPI-05-0401, 16214932.
19. James MR, Hayward NK, Dumenil T, Montgomery GW, Martin NG, Duffy DL. Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia. J Invest Dermatol 2004, 123(4):760-762. 10.1111/j.0022-202X.2004.23305.x, 15373782.
20. Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, Silva A, Pardal F, Suriano G, Machado JC, Lopes JM, et al. Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res 2007, 13(9):2621-2626. 10.1158/1078-0432.CCR-06-2606, 17473192.
21. Vauleon E, Auger N, Benouaich-Amiel A, Laigle-Donadey F, Kaloshi G, Lejeune J, Delattre JY, Thillet J, Sanson M. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 2007, 172(1):33-37. 10.1016/j.cancergencyto.2006.07.013, 17175377.
22. Liu Y, Zhang H, Zhou K, Chen L, Xu Z, Zhong Y, Liu H, Li R, Shugart YY, Wei Q, et al. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis 2007, 28(9):1906-1913. 10.1093/carcin/bgm073, 17389609.
23. Hawkins DM. The problem of overfitting. J Chem Inf Comput Sci 2004, 44(1):1-12.
24. Ron E, Modan B, Boice JD, Alfandary E, Stovall M, Chetrit A, Katz L. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988, 319(16):1033-1039.
25. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003, 284(1):31-53. 10.1016/S0014-4827(02)00098-8, 12648464.
26. Pastore S, Mascia F, Mariani V, Girolomoni G. The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 2008, 128(6):1365-1374. 10.1038/sj.jid.5701184, 18049451.
27. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Research 2004, 64(4):1220-1223. 10.1158/0008-5472.CAN-03-3137, 14973082.
28. Sauter G, Maeda T, Waldman FM, Davis RL, Feuerstein BG. Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am J Pathol 1996, 148(4):1047-1053. 1861518, 8644846.
29. Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky A, Dyson NJ. Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res 2001, 7(8):2387-2395.
30. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, et al. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 2008, 299(1):53-60. 10.1001/jama.2007.65, 18167406.
31. Kang S, Kim JW, Park NH, Song YS, Park SY, Kang SB, Lee HP. Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer. International Journal Of Gynecological Cancer: Official Journal Of The International Gynecological Cancer Society 2007, 17(2):492-496.
32. Liu X, Li L, Chen X, Wang X, Mu L, Li Y, Xu Q, Xie Q, Lu F. No association between EGF +61 A/G polymorphism and increased risk of glioma. Int J Biol Markers 2009, 24(2):77-82.
33. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer. Hum Immunol 2008, 69(6):360-367. 10.1016/j.humimm.2008.04.004, 18571008.
34. Goto Y, Ando T, Goto H, Hamajima N. No association between EGF gene polymorphism and gastric cancer. Cancer Epidemiology, Biomarkers & Prevention: A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology 2005, 14(10):2454-2456.
35. Kang HG, Choi JE, Lee WK, Kam S, Cha SI, Kim CH, Jung TH, Park JY. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology 2007, 12(6):902-905. 10.1111/j.1440-1843.2007.01152.x, 17986122.
36. Gao LB, Wei YS, Zhou B, Wang YY, Liang WB, Li C, Li Y, Bai P, Fang WL, Xue H, et al. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma. Cancer Genet Cytogenet 2008, 185(2):69-73. 10.1016/j.cancergencyto.2008.04.019, 18722874.
37. Araujo AP, Ribeiro R, Pinto D, Pereira D, Sousa B, Mauricio J, Lopes C, Medeiros R. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease. DNA Cell Biol 2009, 28(5):265-269. 10.1089/dna.2008.0823, 19388850.
38. Rosenthal N, Schwartz RS. In search of perverse polymorphisms. N Engl J Med 1998, 338(2):122-124. 10.1056/NEJM199801083380210, 9420346.
39. Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, Silva A, Pardal F, Suriano G, Machado JC, Lopes JM, et al. Association between functional EGF+61 polymorphism and glioma risk. Clinical Cancer Research: An Official Journal Of The American Association For Cancer Research 2007, 13(9):2621-2626.
40. Long AD, Langley CH. The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits. Genome Res 1999, 9(8):720-731. 310800, 10447507.
41. Lanuti M, Liu G, Goodwin JM, Zhai R, Fuchs BC, Asomaning K, Su L, Nishioka NS, Tanabe KK, Christiani DC. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res 2008, 14(10):3216-3222. 10.1158/1078-0432.CCR-07-4932, 18483390.
42. Niklinski J, Niklinska W, Chyczewski L, Becker HD, Pluygers E. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications. Eur J Cancer Prev 2001, 10(3):213-226. 10.1097/00008469-200106000-00004, 11432708.
43. Shibata T, Hanada S, Kokubu A, Matsuno Y, Asamura H, Ohta T, Sakamoto M, Hirohashi S. Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma. Cancer Sci 2007, 98(7):985-991. 10.1111/j.1349-7006.2007.00483.x, 17459062.
44. Holick CN, Giovannucci EL, Rosner B, Stampfer MJ, Michaud DS. Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro Oncol 2007, 9(3):326-334. 10.1215/15228517-2007-005, 1907415, 17504930.
45. Zheng T, Cantor KP, Zhang Y, Chiu BC, Lynch CF. Risk of brain glioma not associated with cigarette smoking or use of other tobacco products in Iowa. Cancer Epidemiol Biomarkers Prev 2001, 10(4):413-414.
46. Zhou W, Liu G, Park S, Wang Z, Wain JC, Lynch TJ, Su L, Christiani DC. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(2):491-496. 10.1158/1055-9965.EPI-04-0612, 15734977.
47. Cui L, Pan XM, Ma CF, Shang-Guan J, Yu HB, Chen GX, Wang J. Association Between Epidermal Growth Factor Polymorphism and Esophageal Squamous Cell Carcinoma Susceptibility. Dig Dis Sci 2010, 55:40-5. 10.1007/s10620-008-0700-5, 19172394.
48. Jin G, Miao R, Deng Y, Hu Z, Zhou Y, Tan Y, Wang J, Hua Z, Ding W, Wang L, et al. Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci 2007, 98(6):864-868. 10.1111/j.1349-7006.2007.00463.x, 17433039.
49. Gao LB, Wei YS, Zhou B, Wang YY, Liang WB, Li C, Li Y, Bai P, Fang WL, Xue H, et al. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma. Cancer Genet Cytogenet 2008, 185(2):69-73. 10.1016/j.cancergencyto.2008.04.019, 18722874.
50. Li Y, Xie Q, Lu F, Zhao J, Mao P, Li Z, Liu S, Zhuang H. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients. Liver Int 2009, 30(1):112-8. 10.1111/j.1478-3231.2009.02134.x, 19840254.
51. Wang Y, Tian T, Hu Z, Tang J, Wang S, Wang X, Qin J, Huo X, Gao J, Ke Q, et al. EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women. Breast Cancer Res Treat 2008, 111(2):321-327. 10.1007/s10549-007-9784-4, 17940864.
52. Spindler KL, Nielsen JN, Ornskov D, Brandslund I, Jakobsen A. Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer. Acta Oncol 2007, 46(8):1113-1117. 10.1080/02841860701338853, 17851837.
53. Randerson-Moor JA, Gaut R, Turner F, Whitaker L, Barrett JH, Silva Idos S, Swerdlow A, Bishop DT, Bishop JA. The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility. J Invest Dermatol 2004, 123(4):755-759. 10.1111/j.0022-202X.2004.23304.x, 15373781.
54. Amend KL, Elder JT, Tomsho LP, Bonner JD, Johnson TM, Schwartz J, Berwick M, Gruber SB. EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res 2004, 64(8):2668-2672. 10.1158/0008-5472.CAN-03-3855, 15087376.
55. Lanuti M, Liu G, Goodwin JM, Zhai R, Fuchs BC, Asomaning K, Su L, Nishioka NS, Tanabe KK, Christiani DC. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clinical Cancer Research: An Official Journal Of The American Association For Cancer Research 2008, 14(10):3216-3222. 2572712, 18483390.
56. Casula M, Alaibac M, Pizzichetta MA, Bono R, Ascierto PA, Stanganelli I, Canzanella S, Palomba G, Zattra E, Palmieri G. Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. BMC Dermatol 2009, 9:7. 10.1186/1471-5945-9-7, 2719594, 19624835.
57. Araujo AP, Ribeiro R, Pereira D, Pinto D, Sousa B, Catarino R, Medeiros R. Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene. Exp Biol Med (Maywood) 2009, 234(3):241-245. 10.3181/0805-RM-146, 19144868.
58. Pinto GR, Yoshioka FK, Clara CA, Santos MJ, Almeida JR, Burbano RR, Rey JA, Casartelli C. Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil. Int J Biol Markers 2009, 24(4):277-281.